Newsroom

Actions

151201 PR CRM B3 study EN

Actions

BIOTRONIK Announces Start of Study to Evaluate Benefits of Unique Rate Response Algorithm for Atrial Fibrillation Patients

Randomized, Controlled B3 Trial Will Determine if Closed Loop Stimulation Can Delay Onset of Clinically Relevant AF and Reduce Risk of Stroke






Please contact us if you require further information

${loading}